Diagnostic Tests for Dermatomyositis, Polymyositis, and Thymoma-Associated Myasthenia Gravis
A comprehensive diagnostic workup for dermatomyositis, polymyositis, and thymoma-associated myasthenia gravis should include muscle enzyme testing, autoantibody panels, imaging studies, electrophysiological testing, and tissue biopsy to confirm diagnosis and guide treatment decisions. 1
Diagnostic Tests for Dermatomyositis and Polymyositis
Laboratory Tests
- Muscle enzymes including creatine kinase (CK), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and aldolase - these may be elevated but can sometimes be normal despite active disease 1
- Complete blood count and blood film 1
- Inflammatory markers - erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) 1
- Myositis-specific and myositis-associated antibodies - crucial for classification and prognosis 1
- Renal and liver function tests 1
- Infection screen to rule out infectious causes of myopathy 1
- Thyroid function tests and electrolyte panel to exclude alternative causes of muscle weakness 1
Imaging Studies
- Muscle MRI with T2-weighted/STIR sequences - highly sensitive for detecting muscle inflammation 1
- Chest X-ray and high-resolution CT if pulmonary involvement is suspected 1
- Abdominal ultrasound scan 1
Functional Tests
- Manual Muscle Testing (MMT8) and Childhood Myositis Assessment Scale (CMAS) for formal muscle strength and function evaluation 1
- Pulmonary function tests including carbon monoxide diffusion capacity 1
- Nailfold capillaroscopy - particularly useful for dermatomyositis diagnosis 1
Electrophysiological Testing
- Electromyography (EMG) - to differentiate myopathy from neuropathy and disorders of neuromuscular junction 1
- Nerve conduction studies - particularly when diagnosis is uncertain 1
Tissue Sampling
- Muscle biopsy - essential when presentation is atypical or when skin signs are absent 1
- Standardized biopsy score tool should be used to quantify histological abnormalities 1
- Expert histopathological interpretation is required 1
Diagnostic Tests for Thymoma-Associated Myasthenia Gravis
Laboratory Tests
- Anti-acetylcholine receptor (AChR) antibodies - highly specific for myasthenia gravis 1, 2
- Anti-striated muscle antibodies - often present in thymoma-associated MG 1
- Paraneoplastic autoantibody panel 1
Imaging Studies
Electrophysiological Testing
- Repetitive nerve stimulation - demonstrates decremental response characteristic of neuromuscular junction disorders 1, 2
- Single-fiber EMG - most sensitive test for neuromuscular junction disorders 1
Functional Tests
- Edrophonium (Tensilon) test - rapid, short-acting anticholinesterase that temporarily improves myasthenic weakness 2
- Ice pack test - non-pharmacological test for ocular myasthenia 2
Special Considerations for Overlap Syndromes
Clinical Features Suggesting Myositis-Myasthenia Gravis Overlap
- Presence of bulbar weakness (83% of overlap cases) 2
- Ptosis (33% of overlap cases) 2
- Diplopia (17% of overlap cases) 2
- Fatigable weakness (83% of overlap cases) 2
- Improvement with pyridostigmine (83% of overlap cases) 2
- Worsening with high-dose steroids (33% of overlap cases) 2
Additional Tests for Suspected Overlap Syndromes
- Cardiac evaluation with echocardiogram and ECG - essential for all patients with suspected myositis 1
- Swallow function assessment - particularly important when bulbar symptoms are present 1, 2
- Testing for co-existing autoimmune conditions 5
Diagnostic Pitfalls and Caveats
- Muscle enzymes may be normal despite active myositis 1
- High-dose steroids may worsen symptoms in patients with myasthenia gravis-myositis overlap 2
- EMG does not reliably detect metabolic myopathies, requiring additional workup if these are suspected 1
- Overlap of myasthenia gravis and myositis occurs in approximately 2.3% of myasthenia gravis cases 5
- Thymoma can present with paraneoplastic autoimmune disorders including polymyositis, dermatomyositis, and subclinical myasthenia gravis 3, 4
- Diagnostic criteria may overlap in patients with both conditions, complicating the diagnostic approach 3
Diagnostic Algorithm
- Initial evaluation: Muscle enzyme panel, inflammatory markers, complete blood count 1
- Autoantibody testing: Myositis-specific antibodies, AChR antibodies, anti-striated muscle antibodies 1
- Imaging: Muscle MRI, chest CT/MRI to evaluate for thymoma 1
- Electrophysiological studies: EMG, nerve conduction studies, repetitive nerve stimulation 1
- Tissue sampling: Muscle biopsy when diagnosis remains uncertain 1
- Functional testing: Manual muscle testing, pulmonary function tests, swallow assessment 1